These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23913220)

  • 1. Energy metabolism and changes in cellular composition in ovarian cancer.
    Malek A
    Methods Mol Biol; 2013; 1049():233-8. PubMed ID: 23913220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA networks in ovarian cancer.
    Malek A
    Methods Mol Biol; 2013; 1049():111-7. PubMed ID: 23913213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic profiling of ovarian carcinomas using mass spectrometry.
    Fong MY; McDunn J; Kakar SS
    Methods Mol Biol; 2013; 1049():239-53. PubMed ID: 23913221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration.
    Caneba CA; Bellance N; Yang L; Pabst L; Nagrath D
    Am J Physiol Endocrinol Metab; 2012 Oct; 303(8):E1036-52. PubMed ID: 22895781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New concepts in molecular biology applied to traslational research].
    Mengual L
    Arch Esp Urol; 2013 Jun; 66(5):401-8. PubMed ID: 23793757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Main principles and outcomes of DNA methylation analysis.
    Murphy SK; Bassil CF; Huang Z
    Methods Mol Biol; 2013; 1049():67-74. PubMed ID: 23913209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA profiling in ovarian cancer.
    Iorio MV; Croce CM
    Methods Mol Biol; 2013; 1049():187-97. PubMed ID: 23913217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-Linked glycome and proteome of high-molecular-mass proteins in human ovarian cancer ascites: Identification of sulfation, disialic acid and O-linked fucose.
    Karlsson NG; McGuckin MA
    Glycobiology; 2012 Jul; 22(7):918-29. PubMed ID: 22422444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray-based transcriptome profiling of ovarian cancer cells.
    Cui J; Xu Y; Puett D
    Methods Mol Biol; 2013; 1049():119-37. PubMed ID: 23913214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early events in ovarian oncogenesis.
    Cvetkovic D
    Reprod Biol Endocrinol; 2003 Oct; 1():68. PubMed ID: 14577833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep transcriptome profiling of ovarian cancer cells using next-generation sequencing approach.
    Li L; Liu J; Yu W; Lou X; Huang B; Lin B
    Methods Mol Biol; 2013; 1049():139-69. PubMed ID: 23913215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells.
    Abedini MR; Muller EJ; Brun J; Bergeron R; Gray DA; Tsang BK
    Cancer Res; 2008 Jun; 68(12):4511-7. PubMed ID: 18559494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of co- and post-translational modifications of proteins by in vitro and in vivo metabolic labeling].
    Utsumi T
    Seikagaku; 2003 May; 75(5):373-8. PubMed ID: 12822434
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteomic analysis of laser microdissected ovarian cancer tissue with SELDI-TOF MS.
    Cadron I; Van Gorp T; Moerman P; Waelkens E; Vergote I
    Methods Mol Biol; 2011; 755():155-63. PubMed ID: 21761301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GADD45A is a mediator of CD437 induced apoptosis in ovarian carcinoma cells.
    Jiang T; Soprano DR; Soprano KJ
    J Cell Physiol; 2007 Sep; 212(3):771-9. PubMed ID: 17474084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of proteomics in ovarian cancer: which sample should be used?
    Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
    Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
    Jones MB; Krutzsch H; Shu H; Zhao Y; Liotta LA; Kohn EC; Petricoin EF
    Proteomics; 2002 Jan; 2(1):76-84. PubMed ID: 11788994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 31P-magnetic resonance spectra of ovarian cancer cells exposed to chemotherapy within a three-dimensional Matrigel construct.
    Abramov Y; Carmi S; Cohen JS; Anteby SO; Ringel I
    Oncol Rep; 2012 Aug; 28(2):735-41. PubMed ID: 22581188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein profiles in human ovarian cancer cell lines correspond to their metabolic activity and to metabolic profiles of respective tumor xenografts.
    Fabian C; Koetz L; Favaro E; Indraccolo S; Mueller-Klieser W; Sattler UG
    FEBS J; 2012 Mar; 279(5):882-91. PubMed ID: 22240028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioenergetic metabolism in ovarian cancer treated with cyclophosphane in combination with hyperbaric oxygenation].
    Zel'vin BM; Vedernikova NV
    Vopr Onkol; 1979; 25(11):85-6. PubMed ID: 516573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.